These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12802214)

  • 1. Pharmaceuticals and worker productivity loss: a critical review of the literature.
    Burton WN; Morrison A; Wertheimer AI
    J Occup Environ Med; 2003 Jun; 45(6):610-21. PubMed ID: 12802214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Productivity loss and productivity loss costs to United States employers due to priority conditions: a systematic review.
    Rojanasarot S; Bhattacharyya SK; Edwards N
    J Med Econ; 2023; 26(1):262-270. PubMed ID: 36695516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of appropriate pharmaceutical therapy for chronic conditions on direct medical costs and workplace productivity: a review of the literature.
    Goldfarb N; Weston C; Hartmann CW; Sikirica M; Crawford A; He H; Howell J; Maio V; Clarke J; Nuthulaganti B; Cobb N
    Dis Manag; 2004; 7(1):61-75. PubMed ID: 15035834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.
    Lo Sasso AT; Rost K; Beck A
    Med Care; 2006 Apr; 44(4):352-8. PubMed ID: 16565636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Productivity costs before and after absence from work: as important as common?
    Brouwer WB; van Exel NJ; Koopmanschap MA; Rutten FF
    Health Policy; 2002 Aug; 61(2):173-87. PubMed ID: 12088890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
    Vicente-Herrero T; Burke TA; Laínez MJ
    Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Workplace costs associated with acute exacerbation of chronic bronchitis: a comparison of moxifloxacin and levofloxacin.
    Li-McLeod J; Perfetto EM
    Manag Care Interface; 2001 Feb; 14(2):52-9. PubMed ID: 11228817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Back pain and productivity: measuring worker productivity from an employer's perspective.
    Joish VN; Brixner DI
    J Pain Palliat Care Pharmacother; 2004; 18(2):79-85. PubMed ID: 15257978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999.
    Goetzel RZ; Hawkins K; Ozminkowski RJ; Wang S
    J Occup Environ Med; 2003 Jan; 45(1):5-14. PubMed ID: 12553174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost and impact of health conditions on presenteeism to employers: a review of the literature.
    Schultz AB; Chen CY; Edington DW
    Pharmacoeconomics; 2009; 27(5):365-78. PubMed ID: 19586075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective.
    Lamb CE; Ratner PH; Johnson CE; Ambegaonkar AJ; Joshi AV; Day D; Sampson N; Eng B
    Curr Med Res Opin; 2006 Jun; 22(6):1203-10. PubMed ID: 16846553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Employer-incurred health care costs and productivity losses associated with influenza.
    Karve S; Misurski DA; Meier G; Davis KL
    Hum Vaccin Immunother; 2013 Apr; 9(4):841-57. PubMed ID: 23321849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total costs of IBS: employer and managed care perspective.
    Cash B; Sullivan S; Barghout V
    Am J Manag Care; 2005 Apr; 11(1 Suppl):S7-16. PubMed ID: 15926759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment in work productivity and health-related quality of life in patients with IBS.
    Dean BB; Aguilar D; Barghout V; Kahler KH; Frech F; Groves D; Ofman JJ
    Am J Manag Care; 2005 Apr; 11(1 Suppl):S17-26. PubMed ID: 15926760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and model.
    Gerth WC; Sarma S; Hu XH; Silberstein SD
    J Occup Environ Med; 2004 Jan; 46(1):48-54. PubMed ID: 14724478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Employer benefit design considerations for the era of biotech drugs.
    Vogenberg FR; Holland JP; Liebeskind D
    J Occup Environ Med; 2007 Jun; 49(6):626-32. PubMed ID: 17563605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of productivity losses associated with allergic rhinitis.
    Crystal-Peters J; Crown WH; Goetzel RZ; Schutt DC
    Am J Manag Care; 2000 Mar; 6(3):373-8. PubMed ID: 10977437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of methods to measure health-related productivity loss.
    Mattke S; Balakrishnan A; Bergamo G; Newberry SJ
    Am J Manag Care; 2007 Apr; 13(4):211-7. PubMed ID: 17408341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus-based findings and recommendations for estimating the costs of health-related productivity loss from a company's perspective.
    Uegaki K; de Bruijne MC; Anema JR; van der Beek AJ; van Tulder MW; van Mechelen W
    Scand J Work Environ Health; 2007 Apr; 33(2):122-30. PubMed ID: 17460800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study.
    Palmer LA; Rousculp MD; Johnston SS; Mahadevia PJ; Nichol KL
    Vaccine; 2010 Jul; 28(31):5049-56. PubMed ID: 20493819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.